VINCRISTINE HOSPIRA 2 mg/2 ml, solution injectable — 5 flacon(s) en verre suremballée(s)/surpochée(s) un film plastique (Onco-Tain®) de 2 ml
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400937953948 -
CIP7
3795394 -
CIS
60219803
What the source publishes
- Holder
- PFIZER HOLDING FRANCE
- Active ingredients
- SULFATE DE VINCRISTINE
- Form
- solution injectable
- Package
- 5 flacon(s) en verre suremballée(s)/surpochée(s) un film plastique (Onco-Tain®) de 2 ml
- Routes
- intraveineuse
- Administrative status
- authorised
- Supply regime
- médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE
- Marketing status
- Déclaration de commercialisation
- Authorised on
- 1997-08-18
- Prescription
- Prescription or restricted
Names this record is found by
- VINCRISTINE HOSPIRA 2 mg/2 ml, solution injectable — 5 flacon(s) en verre suremballée(s)/surpochée(s) un film plastique (Onco-Tain®) de 2 ml
- VINCRISTINE HOSPIRA 2 mg/2 ml, solution injectable
- SULFATE DE VINCRISTINE
Complete source data
{
"cis": "60219803",
"cip7": "3795394",
"form": "solution injectable",
"name": "VINCRISTINE HOSPIRA 2 mg/2 ml, solution injectable — 5 flacon(s) en verre suremballée(s)/surpochée(s) un film plastique (Onco-Tain®) de 2 ml",
"cip13": "3400937953948",
"holder": "PFIZER HOLDING FRANCE",
"routes": [
"intraveineuse"
],
"holders": [
"PFIZER HOLDING FRANCE"
],
"currency": "EUR",
"marketed": true,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": "75.87",
"authorisedOn": "1997-08-18",
"compositions": [
{
"name": "SULFATE DE VINCRISTINE",
"nature": "SA",
"strength": "2 mg",
"linkageNumber": "1",
"substanceCode": "05113",
"dosageReference": "2 ml",
"pharmaceuticalElement": "solution"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE",
"dispensingFee": "1.02",
"medicinePrice": "74.85",
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "VINCRISTINE HOSPIRA 2 mg/2 ml, solution injectable",
"marketingStatus": "Déclaration de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-01-08",
"CIS_CIP_bdpm": "2026-11-19",
"CIS_CPD_bdpm": "2026-01-08",
"CIS_COMPO_bdpm": "2026-01-08"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "oui",
"packageDescription": "5 flacon(s) en verre suremballée(s)/surpochée(s) un film plastique (Onco-Tain®) de 2 ml",
"patientEligibility": "not-assessed",
"reimbursementRates": [
"100%"
],
"marketingDeclaredOn": "2007-10-30",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"SULFATE DE VINCRISTINE"
],
"authorisationProcedure": "Procédure nationale",
"prescriptionConditions": [
"médicament nécessitant une surveillance particulière pendant le traitement",
"prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE",
"prescription réservée aux spécialistes et services HEMATOLOGIE",
"prescription hospitalière",
"liste I",
"prescription réservée aux médecins compétents en CANCEROLOGIE"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": null,
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400937953948"